Evidence map›Paper›PMID 36073726›Full record

ReviewChemistry (Weinheim an der Bergstrasse, Germany)2022

Hydrophilic Chitosan Derivatives: Synthesis and Applications.

Erez Cohen, Elena Poverenov

Open access · hybridAbstract readReview
In one paragraph

Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. ROS-responsive HBioactive materials · 2027
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Cell-Free DNA-Based Theranostics for Inflammatory Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Synthesis of Chitosan and Ferric-Ion (FeBiomimetics (Basel, Switzerland) · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Erez CohenAgro-Nanotechnology and Advanced Materials Center, Institute of Postharvest and Food Sciences, Agriculture Research Organization, The Volcani Institute, 68 HaMacabim Road, Rishon LeZion, 7505101, Israel.
Elena PoverenovAgro-Nanotechnology and Advanced Materials Center, Institute of Postharvest and Food Sciences, Agriculture Research Organization, The Volcani Institute, 68 HaMacabim Road, Rishon LeZion, 7505101, Israel.ORCID http://orcid.org/0000-0003-1646-2624
Agricultural Research Organization · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymer alternatives sourced from nature have attracted increasing attention for applications in medicine, cosmetics, agriculture, food, water purification, and more. Among them, chitosan is the most versatile due to its full biodegradability, exceptional biocompatibility, multipurpose bioactivity, and low toxicity. Although remarkable progress has been made in its synthetic modification by using C3/C6 secondary/primary hydroxy (-OH) and the C2 amino (-NH

Indexed as

ChitosanHydrophobic and Hydrophilic InteractionsSolubilityChitosanantibacterialbiopolymerschitosanhydrophilic substitutionnanoparticles

Identifiers

PMID36073726
PMCPMC10092422
OpenAlexW4294954891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.